ustekinumab-aekn Selarsdi

Selected indexed studies

• Mirikizumab (Omvoh) - an IL-23 antagonist for Crohn's disease. (Med Lett Drugs Ther, 2025) [PMID:40324965]

_Worker-drafted node — pending editorial review._